☆ 4.7 Article

Induction of high affinity monoclonal antibodies against SARS-CoV-2 variant infection using a DNA prime-protein boost strategy

JOURNAL OF BIOMEDICAL SCIENCE (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Virology

Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines

Yusha Araf et al.

Summary: The Omicron variant of SARS-CoV-2 is a heavily mutated virus with a high risk of infection. Limited information is available regarding the genomics, transmissibility, and effectiveness of vaccines against this variant, emphasizing the need for further investigation.

JOURNAL OF MEDICAL VIROLOGY (2022)

添加到收藏夹

Article Immunology

Severity of Severe Acute Respiratory System Coronavirus 2 (SARS-CoV-2) Alpha Variant (B.1.1.7) in England

Daniel J. Grint et al.

Summary: The study found that the SARS-CoV-2 alpha variant is more transmissible and associated with increased rates of hospitalization and mortality compared to the wild-type virus in England between November 16, 2020 and January 11, 2021.

CLINICAL INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Medicine, Research & Experimental

Monoclonal antibody targeting the conserved region of the SARS-CoV-2 spike to overcome viral variants

Wan-Ling Wu et al.

Summary: Most therapeutic monoclonal antibodies (mAbs) target the receptor-binding domain (RBD) of SARS-CoV-2 spike protein, which is prone to mutations in variants. However, we identified mAbs that recognize the non-mutated S2 region of the spike protein and can neutralize SARS-CoV-2 infection and protect animals. Humanization of variable region sequences led to the selection of a high-affinity humanized mAb, hMab5.17, which effectively neutralized both SARS-CoV-2 and its variants. This suggests that an mAb targeting the S2 region could serve as a potential universal therapeutic for COVID-19.

JCI INSIGHT (2022)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Rapid, high-yield production of full-length SARS-CoV-2 spike ectodomain by transient gene expression in CHO cells

Matthew Stuible et al.

Summary: Recombinant forms of the spike protein of SARS-CoV-2 and related viruses have proven difficult to produce with good yields in mammalian cells. However, through exploring new transient gene expression methods and a high-cell-density protocol using specific cells, researchers have successfully produced highly homogenous preparations of full-length spike protein with good yields. The efficient two-step affinity purification method developed in this study also contributed to the high productivity of the production process.

JOURNAL OF BIOTECHNOLOGY (2021)

添加到收藏夹

News Item Multidisciplinary Sciences

FAST-SPREADING COVID VARIANT CAN ELUDE IMMUNE RESPONSES

Ewen Callaway

NATURE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Stabilizing the closed SARS-CoV-2 spike trimer

Jarek Juraszek et al.

Summary: Researchers have successfully created a stable variant of the SARS-CoV-2 S protein through structure-based design, with increased expression and correct folding predominantly in a closed prefusion conformation. This contributes to supporting vaccine development efforts.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Cell Biology

D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction

Sophie M-C Gobeil et al.

Summary: The study found that the mutation variant G614 of SARS-CoV-2 leads to significant changes in the protein structure, resulting in altered positioning ratio of RBD, which may have implications for vaccine design.

CELL REPORTS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7

Pengfei Wang et al.

Summary: The COVID-19 pandemic has had global repercussions, with promising vaccines and monoclonal antibody therapies. However, newly detected variants of SARS-CoV-2 present challenges to these treatment options.

NATURE (2021)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Molecular Analysis and Genome Sequencing of SARS-CoV-2 during Second Wave 2021 Revealed Variant Diversity in India

Rupinder Bakshi et al.

Summary: The rapid emergence of SARS-CoV-2 variants presents a critical challenge in controlling the pandemic. This study found the presence of various variants, with B.1.1.7 and B.1.617.2 being the most dominant in the male population aged 21-40 in the Malwa region of Punjab.

JOURNAL OF PURE AND APPLIED MICROBIOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Recombinant Protein Expression and Purification of N, S1, and RBD of SARS-CoV-2 from Mammalian Cells and Their Potential Applications

Julio Garcia-Cordero et al.

Summary: The study successfully designed and optimized the expression of recombinant S1 and N proteins from SARS-CoV-2, demonstrating their immunogenic properties in a mouse model. Enzyme-linked immunosorbent assays confirmed the suitability of these viral antigens for identifying patients infected with COVID-19.

DIAGNOSTICS (2021)

添加到收藏夹

Article Immunology

Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species

Ruoke Wang et al.

Summary: Research shows that the South African B.1.351 variant exhibits the highest resistance to current monoclonal antibodies and convalescent plasma from COVID-19-infected individuals, and the molecular basis for this resistance and potential antibody escape has been identified.

IMMUNITY (2021)

添加到收藏夹

Article Virology

Genomic monitoring unveil the early detection of the SARS-CoV-2 B.1.351 (beta) variant (20H/501Y.V2) in Brazil

Svetoslav N. Slavov et al.

Summary: Sao Paulo State in Brazil is facing a second wave of COVID-19, with a network established to monitor the spread of SARS-CoV-2 variants. Analysis of 210 genomes revealed multiple circulating lineages, with the P.1 lineage predominant and the first detection of the South African B.1.351 (beta) variant in Brazil. Vigilant monitoring is crucial for pandemic control and vaccination strategies.

JOURNAL OF MEDICAL VIROLOGY (2021)

添加到收藏夹

Review Microbiology

SARS-CoV-2 variants, spike mutations and immune escape

William T. Harvey et al.

Summary: The evolution of SARS-CoV-2 has been characterized by the emergence of mutations and variants that impact virus characteristics. Manufacturers are preparing for possible updates to vaccines in response to changes in the virus population, and it is crucial to monitor genetic and antigenic changes alongside experiments to understand the impacts of mutations.

NATURE REVIEWS MICROBIOLOGY (2021)

添加到收藏夹

Article Microbiology

Murine Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV-2 Neutralize Authentic Wild-Type SARS-CoV-2 as Well as B.1.1.7 and B.1.351 Viruses and Protect In Vivo in a Mouse Model in a Neutralization-Dependent Manner

Fatima Amanat et al.

Summary: In this study, mouse monoclonal antibodies were generated against different epitopes on the RBD of SARS-CoV-2, demonstrating that neutralizing antibodies can lower viral titers in the lungs while non-neutralizing antibodies cannot. Most of the MAbs also cross-neutralize the B.1.351 and B.1.1.7 variants in vitro.

MBIO (2021)

添加到收藏夹

Article Infectious Diseases

DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss

Kit Man Chai et al.

Summary: Efficient vaccines against COVID-19 are urgently needed, with the spike protein of SARS-CoV-2 as a major target. A DNA vaccine delivery via electroporation showed promising results in inducing antibodies and neutralizing antibodies, especially with the ability to induce strong Th1-biased responses.

PLOS NEGLECTED TROPICAL DISEASES (2021)

添加到收藏夹

Article Microbiology

Current status of therapeutic monoclonal antibodies against SARS-CoV-2

Sanjeev Kumar et al.

PLOS PATHOGENS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion

Petra Mlcochova et al.

Summary: The B.1.617.2 (Delta) variant of SARS-CoV-2 has lower sensitivity to antibodies and higher replication efficiency compared to other lineages, which may contribute to its dominance and reduced vaccine effectiveness, highlighting the need for continued infection control measures post-vaccination.

NATURE (2021)

添加到收藏夹

Article Cell Biology

Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016

Tyler N. Starr et al.

Summary: The study mapped mutations to the SARS-CoV-2 spike receptor-binding domain that escape binding by certain monoclonal antibodies. These mutations are concentrated in specific lineages of SARS-CoV-2. The authors suggest diversifying the epitopes targeted by antibodies and antibody cocktails to make them more resilient to SARS-CoV-2 antigenic evolution.

CELL REPORTS MEDICINE (2021)

添加到收藏夹

Article Immunology

Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies

Chunyan Yi et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

A human monoclonal antibody blocking SARS-CoV-2 infection

Chunyan Wang et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Article Multidisciplinary Sciences

A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2

Rui Shi et al.

NATURE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Jun Lan et al.

NATURE (2020)

添加到收藏夹

Review Chemistry, Multidisciplinary

Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19

Yuan Huang et al.

ACTA PHARMACOLOGICA SINICA (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies

Ahmed O. Hassan et al.

CELL (2020)

添加到收藏夹

Article Microbiology

Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT-qPCR primer-probe sets

Chantal B. F. Vogels et al.

NATURE MICROBIOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development

Masaki Imai et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies

Alina Baum et al.

SCIENCE (2020)

添加到收藏夹

Article Parasitology

Genomic and phylogenetic characterisation of an imported case of SARS-CoV-2 in Amazonas State, Brazil

Valdinete Alves do Nascimento et al.

MEMORIAS DO INSTITUTO OSWALDO CRUZ (2020)

添加到收藏夹

Article Immunology

Comparison of homologous and heterologous prime-boost immunizations combining MVA-vectored and plant-derived VP2 as a strategy against IBDV

Matias Richetta et al.

VACCINE (2017)

添加到收藏夹

Article Microbiology

Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection

Amelia K. Pinto et al.

MBIO (2015)

添加到收藏夹

Article Medicine, General & Internal

Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia

Ali Moh Zaki et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

添加到收藏夹

Article Immunology

Antibody responses elicited through homologous or heterologous prime-boost DNA and protein vaccinations differ in functional activity and avidity

Michael Vaine et al.

VACCINE (2010)

添加到收藏夹

Article Cell Biology

Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (SARS-CoV)

SC Lai et al.

JOURNAL OF BIOMEDICAL SCIENCE (2005)

添加到收藏夹

Review Pediatrics

SARS: the first pandemic of the 21st century

JD Cherry et al.

PEDIATRIC RESEARCH (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.